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Nitric oxide synthasesAbstract Introduction: Hypercholesterolemia is a major risk factor for the development of athero-
sclerosis and endothelial dysfunction. Chelating agents may play a modulatory role in atheroscle-
rosis by removal of calcium from atherosclerotic plaques.
Aim: The present study aimed to explore the effects of calcium disodium ethylenediaminetetraace-
tic acid (CaNa2EDTA) and meso-2,3-dimercaptosuccinic acid (DMSA) on diet-induced hypercho-
lesterolemia in rats using simvastatin as a reference standard.
Methods: Hypercholesterolemia was induced by feeding rats with cholesterol-rich diet for six
weeks. Rats were divided into ﬁve groups (n= 8): normal control, hypercholesterolemic control,
simvastatin (20 mg/kg; p.o.), CaNa2EDTA (100 mg/kg; i.p.) and DMSA (100 mg/kg; i.p.). Treat-
ments continued daily for the six weeks of diet feeding.
Results: Diet-induced hypercholesterolemia resulted in alterations in the lipid proﬁle markers and
a state of oxidative stress coupled by compensatory increase in serum nitric oxide (NO) level and
decreased aortic endothelial nitric oxide synthase (eNOS) activity parallel to increased inducible
nitric oxide synthase (iNOS) activity, aortic calcium content and aortic wall thickness. Treatment
with simvastatin, CaNa2EDTA and DMSA improved lipid proﬁle and oxidative stress markers.
In addition, they attenuated hypercholesterolemia-induced changes in serum NO level, aortic eNOS
and iNOS activities, calcium content and aortic wall thickness.
Table 1 Effect of six week daily ad
meso-2,3-dimercaptosuccinic acid (D
Groups T
Normal control 5
Hypercholesterolemic control 1
Simvastatin (20 mg/kg; p.o.) 8
CaNa2EDTA (100 mg/kg; i.p.) 8
DMSA (100 mg/kg; i.p.) 7
TC: total cholesterol; TG: triglyceride
erogenic index.
Values are expressed as means ± S.E.
Statistics was carried out by ANOVA
* Signiﬁcantly different from normal c
@ Signiﬁcantly different from hypercho
b Signiﬁcantly different from simvasta
28 H.M. Mahmoud et al.Conclusion: Pretreatment of hypercholesterolemic rats with simvastatin, CaNa2EDTA or DMSA
attenuated most of the changes induced by feeding rats with cholesterol-rich diet owing to their
observed anti-hyperlipidemic and antioxidant properties.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
Open access under CC BY-NC-ND license.1. Introduction
Hyperlipidemia is a major cause for atherosclerosis and its
associated conditions as coronary artery, ischemic cerebrovas-
cular and peripheral vascular diseases.1,2 Feeding animals with
cholesterol-rich diet is commonly used as a model for induc-
tion of hypercholesterolemia to study the etiology of hypercho-
lesterolemia-related metabolic disorders and the efﬁciency of
anti-hypercholesterolemic agents.3,4
Simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A
(HMG-CoA) reductase inhibitor, is commonly used to reduce
blood lipids and to treat cardiovascular diseases including
myocardial infarction, stroke and hypertension.5,6 It possesses
additional pleiotropic effects including antioxidant, anti-
inﬂammatory and immune-modulatory properties.7,8
Calcium disodium ethylenediaminetetraacetic acid
(CaNa2EDTA) and meso-2,3-dimercaptosuccinic acid
(DMSA) possess antioxidant properties in addition to their
calcium chelating ability.9–11 They are widely used for treat-
ment of heavy metal toxicities.10–12 Chelating agents can im-
prove atherosclerosis and cardiovascular diseases via their
ability to chelate ectopic or metastatic calcium from athero-
sclerotic plaques.13,14 On the other hand, other investigators
pointed to the modest role of chelation therapy in
atherosclerosis.15,16
The present study aimed to investigate the protective effects
of CaNa2EDTA and DMSA on diet-induced hypercholesterol-
emia in rats and to compare their effects with that of simvasta-
tin. To achieve the goals of the study, the effects of the
aforementioned agents were evaluated on markers of lipid pro-
ﬁle and oxidative stress. As endothelial dysfunction, vascular
calciﬁcation and aortic wall thickening are among the common
features of atherosclerosis,17,18 the current study aimed to as-
sess the effects of the aforementioned agents on endothelial
function, aortic calciﬁcation and aortic wall thickness of
hypercholesterolemic rats.ministration of simvastatin, calci
MSA) on serum lipid proﬁle m
C (mg/dl) TG (mg/dl)
4.33 ± 1.52 50.62 ± 1.67
13.6 ± 4.5* 61.25 ± 1.46*
7.11 ± 5.65*,@ 43.26 ± 2.57@
0.33 ± 2.22*,@ 39.99 ± 1.68*,
0.09 ± 2.51*,@ 48.58 ± 1.24@
s; LDL-c: low density lipoprotein
M. (n= 6–8 rats).
followed by Tukey–Kramer multip
ontrol value at p< 0.05.
lesterolemic control value at p<
tin value at p< 0.05.2. Materials and methods
2.1. Animals
Adult male Wistar rats (140–180 g) obtained from the animal
house of Faculty of Pharmacy, Beni-Suef University (Beni-
Suef, Egypt) were used in the present study. The animals were
housed eight per cage, kept under suitable environmental con-
ditions (temperature 22 ± 2 C; humidity 60 ± 4%) with a
12 h light/dark cycle and allowed free access to food and water
ad libitum. All animal experiments in this study were carried
out according to the guidelines of Ethics Committee of Faculty
of Pharmacy, Cairo University.
2.2. Drugs and chemicals
CaNa2EDTA and DMSA were purchased from Sigma-Aldrich
(USA), dissolved in saline and 10% sodium bicarbonate solu-
tion, respectively and administered in a dose of 100 mg/kg;
i.p.12,19 Simvastatin was provided as a gift from Hikma Com-
pany (Egypt), suspended in 1% tween 80 and orally adminis-
tered in a dose of 20 mg/kg.20 Pure cholesterol was obtained
from Winlab (UK), cholic acid was obtained from Biomark
(India) and methyl thiouracil was purchased from Sigma–
Aldrich (USA). Any other chemical used was of the highest
analytical grade.
2.3. Induction of hypercholesterolemia
Hypercholesterolemia was induced by feeding rats for six
weeks with diet composed of cholesterol (1%), cholic acid
(0.2%), lard (4%), egg yolk (7%), methyl thiouracil (0.2%),
sodium chloride (1%), wheat bran (6.6%), wheat ﬂour
(45%) and corn starch (35%) according to the method de-
scribed by Pengzhan et al.21um disodium ethylenediaminetetraacetic acid (CaNa2EDTA) and
arkers in cholesterol-rich diet fed rats.
LDL-c (mg/dl) HDL-c (mg/dl) AIX
17.17 ± 1.57 30.20 ± 1.30 0.76 ± 0.07
56.00 ± 2.79* 22.08 ± 0.92* 3.01 ± 0.14*
32.05 ± 2.07@ 20.72 ± 1.55 1.08 ± 0.19@
@,b 48.58 ± 2.45* 27.81 ± 0.99 2.04 ± 0.17*,@
32.12 ± 3.03*,@ 31.29 ± 1.11@,b 1.13 ± 0.11@
cholesterol; HDL-c: high density lipoprotein cholesterol; AIX: ath-
le comparisons test.
0.05.
Figure 1 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on serum thiobarbituric acid reactive
substance (TBARS) level of cholesterol-rich diet fed-rats. Each bar
represents the mean ± S.E.M. (n= 6–8). Statistics was carried
out by ANOVA followed by Tukey-Kramer multiple comparisons
test. *Signiﬁcantly different from the normal control group at
p< 0.05. @Signiﬁcantly different from the hypercholesterolemic
control group at p< 0.05. bSigniﬁcantly different from the
simvastatin group at p< 0.05.
Figure 3 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on blood superoxide dismutase (SOD)
activity level in rats fed with cholesterol rich diet. Each bar
represents the mean ± S.E.M. (n= 6–8). Statistics was carried
out by ANOVA followed by Tukey–Kramer multiple comparisons
test. *Signiﬁcantly different from the normal control group at
p< 0.05. @Signiﬁcantly different from the hypercholesterolemic
control group at p< 0.05.
Figure 4 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on serum total nitrate/nitrite (NOx)
level in rats fed with cholesterol rich diet. Each bar represents the
mean ± S.E.M. (n= 6–8). Statistics was carried out by ANOVA
followed by Tukey–Kramer multiple comparisons test. *Signiﬁ-
cantly different from the normal control group at p< 0.05.
@Signiﬁcantly different from the hypercholesterolemic control
group at p< 0.05.
Figure 2 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on blood reduced glutathione (GSH)
level in rats fed with cholesterol rich diet. Each bar represents the
mean ± S.E.M. (n= 6–8). Statistics was carried out by ANOVA
followed by Tukey-Kramer multiple comparisons test. *Signiﬁ-
cantly different from the normal control group at p< 0.05.
@Signiﬁcantly different from the hypercholesterolemic control
group at p< 0.05.
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Rats were randomly divided into ﬁve groups (n= 8). Group I
(normal control) and Group II (hypercholesterolemic control)
received saline (i.p.). Groups III–V received simvastatin
(20 mg/kg; p.o.), CaNa2EDTA (100 mg/kg; i.p.) and DMSA(100 mg/kg; i.p.), respectively for six weeks. Group I was fed
with normal rat chow while groups II–V were fed on choles-
terol-rich diet throughout the period of investigation
(6 weeks). At the end of the experimental period, blood sam-
ples were collected from 18 h fasted rats for estimation of
blood superoxide dismutase (SOD) activity and the levels of
reduced glutathione (GSH), total cholesterol (TC), triglycer-
ides (TG), high density lipoprotein cholesterol (HDL-c), lipid
Figure 5 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on aortic endothelial nitric oxide
synthase (eNOS) activity in rats fed with cholesterol rich diet.
Each bar represents the mean ± S.E.M. (n= 6). Statistics was
carried out by ANOVA followed by Tukey-Kramer multiple
comparisons test. *Signiﬁcantly different from the normal control
group at p< 0.05. @Signiﬁcantly different from the hypercholes-
terolemic control group at p< 0.05.
30 H.M. Mahmoud et al.peroxides and nitric oxide (NO). Thereafter, animals were sac-
riﬁced by decapitation and aortae were isolated. The isolated
aortae were washed with Krebs solution, freed from connective
tissues and fat, blotted dry and weighed. Part of the aortae was
used for the determination of aortic calcium content and the
other part was used for immunohistochemical determination
of aortic endothelial nitric oxide synthase (eNOS) and induc-
ible nitric oxide synthase (iNOS) activities. In addition, the
wall thickness of aortae was measured in all animals.
2.5. Biochemical estimations
2.5.1. Estimation of serum lipid proﬁle
Serum TC, TG and HDL-c levels were estimated using com-
mercial reagent
kits (Biomed diagnostic, Egypt) and expressed as mg/dl.
Serum low density lipoprotein cholesterol (LDL-c) level
was calculated according to the formula developed by
Friedewald et al.22 as follows:
Serum LDL-c ¼ TC ðHDL-cþ TG=5Þ:
Atherogenic index was calculated according to the formula
adopted by Hostmark et al.23 as follows:
Atherogenic index ¼ ðTC-HDL-cÞ=HDL-c:2.5.2. Estimation of serum nitric oxide
Serum NO level was estimated as total nitrate/nitrite (NOx)
using Griess reagent according to the method described by
Miranda et al.24 and expressed as lmol/l.
2.5.3. Estimation of oxidative stress markers
Serum lipid peroxide level was estimated by determination of
the level of thiobarbituric acid reactive substances (TBARS)
that were measured as MDA according to the method de-
scribed by Mihara and Uchiyama25 and expressed as nmol/ml.
Blood SOD activity was determined using the pyrogallol
autoxidation method described by Marklund and Marklund26
and expressed as U/ml.
Blood GSH level was determined according to the method
described by Beutler et al.27 and expressed as mg/dl.
2.5.4. Estimation of aortic calcium content
Aortic calcium content was determined according to the meth-
od of Essalihi et al.28 Portions of aortae were dried at 55 C inTable 2 Effect of six week daily administration of simvastatin, calci
meso-2,3-dimercaptosuccinic acid (DMSA) on aortic calcium conten
Groups Aortic calcium (
Normal control 10.42 ± 0.94
Hypercholesterolemic control 18.26 ± 1.24*
Simvastatin (20 mg/kg; p.o.) 10.24 ± 0.85@
CaNa2EDTA (200 mg/kg; p.o.) 10.65 ± 0.87
@
DMSA (100 mg/kg; i.p.) 6.50 ± 0.61@
Values are expressed as means ± S.E.M. (n= 6–8 rats).
Statistics was carried out by ANOVA followed by Tukey–Kramer multip
* Signiﬁcantly different from normal control value at p< 0.05.
@ Signiﬁcantly different from hypercholesterolemic control value at p<heating blocks and calcium was extracted with 10% formic
acid overnight at 4 C. Calcium contents were then determined
colorimetrically through a reaction with o-cresolphthalein
using a commercial reagent kit (Spainreact, Spain) and
expressed as mg/g wet tissue.
2.6. Immunohistochemical estimation of endothelial
and inducible nitric oxide synthases
Tissue staining was performed according to the method de-
scribed by Martins et al.29 Sections of aortae were cut into
4 lm, then dried in a 65 C oven for 1 h. Slides were placed
in a coplin jar ﬁlled with 200 ml of triology (Cell Marque,
USA) working solution for deparafﬁnization, rehydration
and antigen unmasking. The jar was then securely positioned
in an autoclave adjusted at 120 C for 15 min after which the
pressure was released and slides were allowed to cool for
30 min. Sections were then washed and immersed in tris buffer
to adjust pH. Quenching endogenous peroxidase activity was
performed by immersing slides in 3% hydrogen peroxide forum disodium ethylenediaminetetraacetic acid (CaNa2EDTA) and
t and aortic wall thickness in cholesterol-rich diet fed rats.
mg/g wet tissue) Aortic wall thickness (lm)
80.79 ± 1.38
124.70 ± 8.40*
83.25 ± 1.66@
82.73 ± 3.90@
80.48 ± 1.62@
le comparisons test.
0.05.
Figure 6 Microscopic photographs of endothelial nitric oxide synthase in rats’ thoracic aortae obtained from: (A) Normal control rat,
(B) Hypercholesterolemic control rat, (C) Simvastatin (20 mg/kg)-treated rat, (D) CaNa2EDTA (100 mg/kg)-treated rat and (E) DMSA
(100 mg/kg)-treated rat. (Mayer Hematoxylin X 200).
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Biotechnologies, USA) was used to visualize any antigen-anti-
body reaction in the tissues. Rabbit anti-eNOS (BD Biosci-
ences, UK) and anti-iNOS (Neomarkers, USA) were added
followed by incubation of slides in a humidity chamber over-
night at 4 C. Poly horseradish peroxidase (HRP) enzyme
conjugate was then applied to each slide for 20 min followed
by 3,30-diaminobenzidine chromogen. Counterstaining with
Mayer Hematoxylin was done and slides were examined using
image analyzer computer system utilizing ImageJ software
(NIH, version v1.45e, USA).2.7. Estimation of aortic wall thickness
Mean wall thickness (lm) of six sections from the aortae of
each group was measured using a micrometer scale that was
photographed to allow conversion of the measurements ob-
tained from the camera in pixels into micrometers.2.8. Statistical analysis
Data were expressed as means ± standard error of mean
(SEM). Statistical analysis was performed using GraphPad
Prism Software (version 5, Inc., San Diego, USA). Compari-
son between different groups was done using one way analysis
of variance (ANOVA) followed by Tukey–Kramer multiple
comparisons test. Differences were considered statistically sig-
niﬁcant when p< 0.05.
3. Results
3.1. Effect of simvastatin, CaNa2EDTA and DMSA on serum
lipid proﬁle markers in rats fed with cholesterol rich diet
Feeding rats with cholesterol-rich diet signiﬁcantly increased
serum levels of TC, TG and LDL-c; meanwhile it decreased
serum HDL-c level (Table 1).
Figure 7 Effect of six week daily administration of simvastatin,
CaNa2EDTA and DMSA on aortic inducible nitric oxide synthase
(iNOS) activity in rats fed with cholesterol rich diet. Each bar
represents the mean ± S.E.M. (n= 6). Statistics was carried out
by ANOVA followed by Tukey–Kramer multiple comparisons
test. *Signiﬁcantly different from the normal control group at
p< 0.05. @Signiﬁcantly different from the hypercholesterolemic
control group at p< 0.05.
32 H.M. Mahmoud et al.Treatment with simvastatin, CaNa2EDTA or DMSA de-
creased serum TC level to 76.68%, 70.71% and 61.7%; de-
creased serum TG level to 70.62%, 65.28% and 79.3%,
respectively as compared to the hypercholesterolemic control
group. Moreover, simvastatin and DMSA normalized serum
TG level (Table 1).
Similarly, treatment with simvastatin or DMSA signiﬁ-
cantly decreased serum LDL-c level to 57.23% and 57.36%,
respectively as compared to hypercholesterolemic control
value. Moreover, administration of DMSA signiﬁcantly in-
creased serum HDL-c level to about 141.71% of hypercholes-
terolemic control value and to about 151% of simvastatin
value. Furthermore, CaNa2EDTA or DMSA normalized
serum HDL-c level (Table 1).
Feeding rats with cholesterol-rich diet signiﬁcantly in-
creased atherogenic index; meanwhile treatment with simva-
statin, CaNa2EDTA or DMSA decreased atherogenic index
of hypercholesterolemic rats to 35.88%, 67.77% and
37.54%, respectively as compared with hypercholesterolemic
control value (Table 1).
3.2. Effect of simvastatin, CaNa2EDTA and DMSA on
oxidative stress markers in rats fed with cholesterol rich diet
Feeding rats with cholesterol-rich diet signiﬁcantly increased
serum TBARS level parallel to reduction in blood GSH level
and SOD activity (Figs. 1–3). Treatment with simvastatin,
CaNa2EDTA or DMSA decreased serum TBARS level to
48.38%, 66.45% and 18.75% (Fig. 1) while increasing blood
GSH level to 319.26%, 302.75% and 317.82% (Fig. 2), respec-
tively as compared to hypercholesterolemic control values.
Moreover, CaNa2EDTA and DMSA signiﬁcantly decreased
serum TBARS level to 137.33% and 38.75%, respectively as
compared to the simvastatin group. Regarding SOD, CaNa2-
EDTA and DMSA elevated its activity to 165.7% and163.48% of hypercholesterolemic control value, respectively
(Fig. 3).
3.3. Effect of simvastatin, CaNa2EDTA and DMSA on serum
total nitrate/nitrite level in rats fed with cholesterol rich diet
Feeding rats with cholesterol rich diet signiﬁcantly increased
serum NOx level to 186.86% as compared to the normal
control group. Treatment with simvastatin further increased
serum NOx level to 144.81% as compared with hypercholester-
olemic control value (Fig. 4).
3.4. Effect of simvastatin, CaNa2EDTA and DMSA on aortic
calcium content and aortic wall thickness in rats fed with
cholesterol rich diet
Feeding rats with cholesterol rich diet signiﬁcantly increased
aortic calcium content and aortic wall thickness to 175.24%
and 154.35%, respectively as compared with the normal
control value. Prophylactic treatment of hypercholesterolemic
rats with simvastatin, CaNa2EDTA or DMSA decreased
aortic calcium content to 56.08%, 58.32% and 35.6% parallel
to decreased aortic wall thickness to 66.76%, 66.34% and
64.53%, respectively as compared to hypercholesterolemic
control values (Table 2).
3.5. Effect of simvastatin, CaNa2EDTA and DMSA on aortic
endothelial and inducible nitric oxide synthase activities in rats
fed with cholesterol rich diet
Feeding rats with cholesterol-rich diet signiﬁcantly decreased
aortic eNOS activity parallel to increased iNOS activity
(Figs. 5–8). Prophylactic treatment of hypercholesterolemic
rats with simvastatin, CaNa2EDTA or DMSA signiﬁcantly in-
creased aortic eNOS activity to 180%, 146.66% and 200%
parallel to decreased aortic iNOS activity to 68.42%, 76.31%
and 73.68%, respectively as compared to hypercholesterolemic
control values (Figs. 5–8).
4. Discussion
Data of the present study revealed marked disturbance in
lipid proﬁle of rats fed with cholesterol-rich diet manifested by
increased atherogenic index as well as serum levels of TC, TG
and LDL-c parallel to a decrease in serum HDL-c level.
Similar results were reported by other investigators.30,31
Prophylactic administration of simvastatin, CaNa2EDTA
and DMSA decreased atherogenic index as well as serum levels
of TC and TG. Moreover, DMSA decreased serum LDL-c le-
vel and increased serum HDL-c levels. Beneﬁcial effects of
CaNa2EDTA in atherosclerosis and other cardiovascular dis-
orders were reported in patients14,32 and experimental
animals.33
The mechanism underlying the effect of chelating agents on
lipid proﬁle is unclear. However, the obtained results could be
attributed to the reported antioxidant effects of CaNa2-
EDTA9,34,35 and DMSA10–12,36 which in turn lead to decreased
free radical generation and decreased oxidative damage of the
liver, the main organ involved in cholesterol biosynthesis.
Indeed in the current study, oxidative stress was obvious in
cholesterol rich diet fed-rats as evidenced by the increase in
Figure 8 Microscopic photographs of inducible nitric oxide synthase in rats’ thoracic aortae obtained from: (A) Normal control rat, (B)
Hypercholesterolemic control rat, (C) Simvastatin (20 mg/kg)-treated rat, (D) CaNa2EDTA (100 mg/kg)-treated rat and (E) DMSA
(100 mg/kg)-treated rat. (Mayer Hematoxylin X 200).
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and GSH level. Similar results were previously reported.37
Data of the present work indicated that simvastatin and the
chelating agents used signiﬁcantly decreased cholesterol rich
diet-induced oxidative stress. CaNA2EDTA was reported to
inhibit cell-mediated LDL oxidation38 and to chelate transi-
tional metals which are important catalyst for lipid peroxida-
tion, LDL oxidation and free radical formation.9 Another
explanation for the antioxidant effect of EDTA resides in its
ability to chelate calcium.39 Calcium activates phospholipase-
A2 resulting in increased levels of arachidonic acid which in
turn result in the production of more free radicals.40 Similarly,
increased blood GSH level following DMSA administration in
lead- and arsenic-intoxicated rats was reported.10,36
The current results showed that serum NO level was
signiﬁcantly increased in hypercholesterolemic control rats.
Similar results were previously reported in hypercholesterol-
emic rats41 and patients.42 Increased serum NO level may
be regarded as a defense mechanism to compensate for con-
tinuous inactivation of NO by oxygen-derived free radicals
in hypercholesterolemia43 or it could be a consequence of
increased inducible nitric oxide synthase (iNOS) activity with
cholesterol feeding.44Simvastatin signiﬁcantly increased serum NO level com-
pared to normal and hypercholesterolemic rats which is consis-
tent with the work of Wu et al.45 and could be explained via
the ability of statins to up-regulate eNOS expression.46 In
the same context pretreatment of rats with CaNa2EDTA or
DMSA did not affect hypercholesterolemia-induced increase
in serum NO level. Foglieni et al.47 reported increased expres-
sion of eNOS in EDTA-treated rats. Moreover effects of sim-
vastatin, CaNa2EDTA or DMSA can be explained by their
reported antioxidant effects leading to decreased generation
of oxygen free radicals, decreased oxidative degradation and
increased bioavailability of NO.12,18,48
Diet-induced hypercholesterolemia in rats resulted in a
signiﬁcant decrease in aortic eNOS activity coupled with
increased aortic iNOS activity which is consistent with the
ﬁndings of other investigators.49 Current ﬁndings could be
attributed to hypercholesterolemia-induced oxidative stress
leading eventually to endothelial dysfunction.50
Pretreatment with simvastatin, CaNa2EDTA or DMSA
prevented cholesterol rich diet-induced changes in aortic eNOS
and iNOS activities. Laufs et al.46 demonstrated that simvasta-
tin up-regulates eNOS expression through increasing the
stability of eNOS mRNA. The increased eNOS activity by
34 H.M. Mahmoud et al.CaNa2EDTA or DMSA could be mediated by their ability to
chelate several divalent cations which suppress eNOS activ-
ity.51 DMSA was also reported to decrease cadmium in-
duced-vascular dysfunction and oxidative stress in mice.11
Cholesterol-rich diet feeding resulted in a signiﬁcant
increase in aortic calcium content and wall thickness which is
in accordance with the work of other investigators.45,52 Tang
et al.18 demonstrated that hypercholesterolemia is accompa-
nied by lipid deposition in the vessel resulting in foam cell,
plaque formation and vascular calciﬁcation. Hypercholesterol-
emia is also associated with the production of oxidized LDL
(oxLDL) which is involved in endothelial injury, vascular cal-
ciﬁcation and increased aortic thickness.53,54
In the current investigation, simvastatin signiﬁcantly
decreased aortic calcium content of hypercholesterolemic rats.
The obtained results were supported by the study of Tang
et al.18 which indicated that simvastatin has the ability to
decrease serum oxLDL level, aortic cholesterol ester content
and aortic alkaline phosphatase activity. Simvastatin also
decreased aortic wall thickness in the present study which is
consistent with the studies of other investigators45,55 which
revealed a signiﬁcant correlation between LDL-c lowering ef-
fect of simvastatin and atherosclerotic plaque regression as
well as luminal area increase leading to decreased aortic wall
thickness.
Findings of the present study revealed that using chelating
agents as CaNa2EDTA or DMSA signiﬁcantly decreased aor-
tic calcium content and aortic wall thickness of hypercholester-
olemic rats. Similar ﬁndings were previously reported.13,14
Such ﬁndings could be explained through the ability of EDTA
or DMSA to chelate calcium and other divalent cations39,51
removing the pathologic (ectopic) calcium from both the aortic
wall and atherosclerotic plaque.13 The observed LDL lowering
effect of DMSA may also result in decreased plaque forma-
tion, vascular calciﬁcation and wall thickness.
5. Conclusions
In conclusion, the present study revealed that diet-induced
hypercholesterolemia resulted in alterations in the lipid proﬁle
and a state of oxidative stress coupled by a compensatory in-
crease in serum level of total nitrate/nitrite and decreased aor-
tic eNOS activity as well as increased aortic iNOS activity,
calcium content and wall thickness. Pretreatment of hypercho-
lesterolemic rats with simvastatin, CaNa2EDTA or DMSA
attenuated most of the changes induced in rats by choles-
terol-rich diet. Such ﬁndings may be of considerable value in
the treatment of hypercholesterolemia and atherosclerosis in
clinical practice.
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